Yahoo Web Search

Search results

1. • 

     CMS Issues CY2025 Medicare Advantage and Part D Final Rule

     The National Law Review· 3 days ago

     According to CMS’ Fact Sheet, the Final Rule builds on existing Biden-Harris Administration policies...

2. • 

     Why Is Medicare Part D’s IRMAA Premium So High? - Canyon News

     Canyon News· 1 day ago

     If I do not apply for a Medicare prescription drug plan, do I still have to pay the “extra” $33.30?...

3. • 

     How to save money at the pharmacy counter

     Minneapolis-St. Paul Star Tribune· 4 days ago

     Steve Wexler has experienced the trouble of finding affordable prescription drugs in Minnesota. A few years ago, the 70-year-old Plymouth resident opted...

4. • 

     Why doesn't Medicare cover drugs like Ozempic for weight loss? - Marketplace

     Marketplace· 3 days ago

     Medicare Part D, which provides prescription drug coverage, will now cover the weight-loss...

5. • 

     Biden law will cap Medicare drug cost including cancer drugs

     Politifact· 4 hours ago

     Part of President Joe Biden’s election year pitch to Latino voters includes a promise to lower...

6. • CMS Finalizes Rule Regarding Marketing Changes, Beneficiary Protections, and Coverage for Medicare...

     JD Supra· 3 days ago

     According to the fact sheet accompanying the rule, “the changes in this final rule build on existing Biden-Harris Administration policies to strengthen protections and guardrails...

7. • 

     MedPAC Wrestles With Wide Variation in Generic Rx Prices, Availability

     MedPage Today· 4 days ago

     From a document developed by MedPAC staff, commissioners learned that the price of a generic Part D ...

8. • White House Swings for Fences with FY 2019 Drug Pricing Proposals

     The National Law Review· 1 day ago

     Together these documents provide a framework to address prescription drug pricing and outline a multi-faceted approach that the administration believes ...

9. • 

     Fact check: Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees

     Boston Herald· 1 day ago

     The cost of insulin in the United States has risen considerably in recent years, with some estimates...

10. • HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates

      The National Law Review· 4 days ago

      ...explicitly exclude discounts relating to price reductions or other remuneration offered by a pharmaceutical manufacturer to a Medicare Part D plan sponsor (“Plan Sponsor”), a Medicaid managed care organization (“MCO”), and/or a pharmacy...address on February 5, 2019 – is one of the most...